Skip to main content
Clinical Trials/RBR-4zdtk9n
RBR-4zdtk9n
Not Yet Recruiting
N/A

Effect of neuromodulation on pain and functional mobility of people infected with HTLV-1 randomized clinical trial

Escola Bahiana de Medicina e Saúde Pública0 sitesAugust 15, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
HTLV-I Infections
Sponsor
Escola Bahiana de Medicina e Saúde Pública
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2021
End Date
December 28, 2024
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Escola Bahiana de Medicina e Saúde Pública

Eligibility Criteria

Inclusion Criteria

  • To be included in the protocol, the participant must have: age\> 20 years; be a carrier of HTLV\-1; be a community walker with or without orthosis; with chronic pain (\= 6 months) in the lower back and / or lower limbs and ability to sign the written consent form

Exclusion Criteria

  • Participants should be excluded if they have: history of epilepsy, cancer, are pregnant women; have a cardiac pacemaker and / or metallic implant in the brain or skull; if they have used illicit drugs and / or alcohol in the last six months; if they use controlled medications; and if they are being accompanied in an exercise program in the 30 days prior to the intervention by rTMS.

Outcomes

Primary Outcomes

Not specified

Similar Trials